Vaping and smoking are not the same thing, but they are not as different as many people assume. E-cigarettes heat a liquid into an aerosol rather than burning tobacco, which eliminates the combustion process responsible for thousands of toxic chemicals in cigarette smoke. That distinction matters: e-cigarette aerosol contains far fewer harmful compounds than cigarette smoke. Yet vaping introduces its own set of risks to the lungs, heart, and blood vessels, and both products deliver nicotine in ways that sustain addiction. The gap between “less harmful” and “harmless” is where the real story lives.
What You Actually Inhale
The most fundamental difference is chemistry. Burning tobacco generates a staggeringly complex mixture. E-cigarette aerosol, by contrast, is much simpler. A combined analysis comparing flavored e-cigarette aerosols with reference cigarette smoke found that the aerosols contained roughly 94 to 139 identifiable compounds, while cigarette smoke contains one to two orders of magnitude more. About 89 to 99 percent of the e-cigarette aerosol was made up of glycerol, propylene glycol, water, and nicotine, with only around 3 percent consisting of other minor constituents. For cigarette smoke, the picture was reversed: 58 to 76 percent of the smoke “tar” was made up of minor constituents, many of them toxic. Levels of targeted toxicants in e-cigarette aerosol showed reductions of roughly 88 to over 99 percent compared with cigarette smoke under intense puffing conditions, and reductions against the WHO’s priority toxicant list were around 99 percent.1PubMed Central. The Chemical Complexity of e-Cigarette Aerosols Compared With the Smoke From a Tobacco Burning Cigarette
That sounds reassuring, and in relative terms it is. But “much less toxic” does not mean “nontoxic.” The remaining compounds in e-cigarette aerosol still include carbonyls like formaldehyde and acrolein, volatile organic compounds, and flavoring chemicals whose long-term inhalation effects are poorly understood. And as we will see, other contaminants creep in from the device hardware itself.
Nicotine Delivery and Addictive Potential
Both products deliver nicotine, and both do it fast enough to keep you hooked. In experienced e-cigarette users, average peak blood nicotine levels reached about 8.4 ng/ml within two to five minutes, and the shape of the nicotine absorption curve resembled that of a cigarette, which researchers interpret as a sign of comparable addictive potential.2PubMed Central. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes Newer, more powerful devices narrow the gap further. One study found that a newer-generation e-cigarette raised blood nicotine levels roughly 50 to 70 percent higher than a first-generation device during the same vaping session, with peak levels reaching above 23 ng/ml in extended use.3Scientific Reports. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices
That said, in a direct head-to-head comparison among people who used both products, peak nicotine from e-cigarettes still came in lower than from cigarettes (about 6 ng/ml versus 20 ng/ml on average), and it took longer to reach that peak.4PubMed Central. Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users The practical upshot: e-cigarettes can deliver plenty of nicotine to maintain dependence, especially newer pod-style devices with high-concentration nicotine salts. If you are vaping to avoid addiction, the device itself works against you.
What Happens to Your Lungs
Cigarettes are catastrophic for the lungs over the long term, causing chronic obstructive pulmonary disease, emphysema, and lung cancer. E-cigarettes have not been around long enough to generate decades of data, but the evidence accumulating over shorter timeframes is not encouraging.
A cross-sectional study comparing e-cigarette users, cigarette smokers, and nonsmokers found that vapers had measurably worse airflow and respiratory muscle strength than nonsmokers. Surprisingly, on some measures (peak expiratory flow and respiratory muscle strength), e-cigarette users actually performed worse than cigarette smokers, though smokers fared worse on other indicators.5PubMed. Impact of E-cigarette versus combustible cigarette use on lung function: A cross-sectional study A systematic review looking at short-term exposure found more mixed results: some studies showed brief dips in lung function after vaping that returned to normal within minutes, while others showed no immediate change at all.6npj Primary Care Respiratory Medicine. A systematic review of the effects of e-cigarette use on lung function
The cellular-level picture helps explain why even short-term vaping might matter. E-cigarette aerosol has been shown to slow the beating of cilia (the tiny hair-like projections that sweep debris out of your airways), alter ion channel activity in lung cells, and change the chemical signals those cells send to the immune system.7PubMed. Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells When your lungs cannot clear irritants properly and are sending disrupted immune signals, the stage is set for chronic inflammation even without the tar and carbon monoxide of cigarette smoke.
The EVALI Episode
In 2019, a wave of severe lung injuries connected to vaping made headlines. The condition was eventually called EVALI (e-cigarette, or vaping, product use-associated lung injury). Investigation pinpointed vitamin E acetate, an additive used primarily in illicit THC vape cartridges, as the leading culprit. In a landmark study, vitamin E acetate was found in the lung fluid of 48 out of 51 patients with EVALI, while it was absent in a healthy comparison group. Among case patients with available data, 94 percent had either detectable THC metabolites in their lung fluid or reported vaping THC products in the 90 days before getting sick.8PubMed Central. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
EVALI is worth understanding because it illustrates a risk specific to vaping that has no parallel in traditional smoking: the contents of the liquid you inhale can change without warning. With regulated commercial nicotine e-liquids, the risk of vitamin E acetate exposure is very low. But black-market and self-mixed products can introduce chemicals that your lungs were never meant to encounter. The episode also underscored that propylene glycol and vegetable glycerin, the base liquids in standard e-cigarettes, are not entirely benign when inhaled either. Lab research has linked propylene glycol exposure to markers of fibrotic lung injury and vitamin E acetate exposure to airway inflammation resembling asthma.9PubMed. Comparative study of lung toxicity of E-cigarette ingredients to investigate E-cigarette or vaping product associated lung injury
Cardiovascular Effects
The heart and blood vessels respond to both vaping and smoking, largely because nicotine itself is a powerful stimulant. A meta-analysis found that a single vaping session raised heart rate by about 11 beats per minute and systolic blood pressure by roughly 13 mmHg compared to not using anything. When compared directly to a cigarette, the heart rate spike from vaping was somewhat smaller, though blood pressure rose similarly.10PubMed. Cardiovascular health effects of vaping e-cigarettes: a systematic review and meta-analysis Separate work in nonsmokers confirmed that these cardiovascular effects were driven by nicotine: vaping a nicotine-containing e-cigarette raised heart rate by about 5 beats per minute and mean arterial pressure by about 6.5 mmHg, while a nicotine-free placebo produced no significant change.11PubMed. Acute effects of electronic cigarettes on arterial pressure and peripheral sympathetic activity in young nonsmokers
Longer-term vascular effects are where the comparison gets more nuanced. A review of randomized controlled trials found that e-cigarettes caused less arterial stiffness and endothelial dysfunction than conventional cigarettes. But observational studies comparing vapers to people who use nothing at all still found worse vascular outcomes, including increased arterial stiffness and the development of carotid plaque.12PubMed Central. How Electronic Cigarette Affects the Vascular System In one study, both chronic vapers and smokers had worse blood vessel dilation than nonusers. The blood of e-cigarette users impaired nitric oxide release in endothelial cells, and vaping caused a specific increase in microvascular permeability and oxidative stress that was not seen even with cigarettes.13PubMed Central. Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels
An intriguing finding from work comparing e-cigarettes and cigarettes head-to-head among chronic users: while both raised blood pressure and heart rate, the spike was greater after smoking a combustible cigarette than after vaping, even when the nicotine dose was similar. The researchers attributed the extra blood-pressure jump from cigarettes to non-nicotine combustion products in the smoke.14PubMed Central. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents So cigarettes hit the cardiovascular system harder in the short term, but vaping is clearly not cardiovascularly neutral.
Cancer-Related Biomarkers
Cancer risk is perhaps the biggest long-term question, and one that cannot yet be answered definitively because e-cigarettes have only been widely used for about 15 years. What researchers can measure now are biomarkers of exposure to known carcinogens, and the picture there is fairly consistent. A meta-analysis of urinary biomarkers linked to bladder cancer found that smokers had significantly higher levels of nearly every cancer-related metabolite tested compared to vapers. Key tobacco-specific nitrosamines, polycyclic aromatic hydrocarbon metabolites, and acrolein markers were all substantially elevated in smokers.15PubMed Central. Comparison of bladder carcinogenesis biomarkers in the urine of traditional cigarette users and e-cigarette users U.S. population data spanning 2013 to 2019 confirmed that NNAL, a metabolite of a potent tobacco-specific carcinogen, was consistently far lower in vapers than in smokers.16JAMA. Trends in Urinary Biomarkers of Exposure to Nicotine and Carcinogens Among Adult e-Cigarette Vapers vs Cigarette Smokers in the US, 2013-2019
This is encouraging, but “lower carcinogen exposure” is not the same as “no cancer risk.” A handful of the metabolites tested showed no significant difference between vapers and smokers, meaning e-cigarettes are not eliminating every category of carcinogenic exposure. And cancer can take decades to develop, so even favorable biomarker data today cannot guarantee that long-term vapers will not see elevated cancer rates compared to people who use neither product.
Heavy Metals from the Device Itself
One hazard unique to vaping has nothing to do with the liquid: it comes from the heating coil. E-cigarette coils are typically made from metal alloys containing chromium, nickel, and sometimes other elements. As the device heats and cools over hundreds of puffs, these metals leach into the liquid and end up in the aerosol you inhale. A study tracking disposable e-cigarettes over their full lifecycle found that chromium and nickel concentrations in the aerosol increased by up to 1,000-fold between early use and the end of the device’s life.17ACS Central Science. Elevated Toxic Element Emissions from Popular Disposable E‑Cigarettes: Sources, Life Cycle, and Health Risks Earlier research had documented the same pattern: metal concentrations in the aerosol were substantially higher than in the fresh liquid, pointing to the coil as the source.18PubMed Central. Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils
A risk assessment estimated that roughly one in ten coil extracts could exceed safe daily exposure concentrations for nickel under chronic use scenarios.19PubMed Central. Occurrence of metals in e-cigarette liquids: Influence of coils on metal leaching and exposure assessment Cigarette smoke also contains trace metals, but the mechanism here is different and the concentrations can be unpredictable, varying with device brand, coil material, and how many puffs you have taken. If you vape, using a device well past its intended lifespan increases your metal exposure significantly.
Secondhand Exposure
Secondhand cigarette smoke is an established health hazard. Secondhand e-cigarette aerosol is less studied but measurably different. In a controlled comparison, indoor air nicotine concentrations from e-cigarettes were about one-tenth the level produced by cigarettes.20PubMed Central. Secondhand Exposure to Vapors From Electronic Cigarettes E-cigarette aerosol was a source of secondhand nicotine but not of the combustion toxicants found in cigarette smoke. More recent work found that right at the source, nicotine concentrations from e-cigarettes were comparable to those from cigarettes, but they dropped off much more rapidly with distance.21PubMed. PM1 exposure and spatial transmission of nicotine from the simulated second-hand vapor of pod-based electronic cigarettes That faster dropoff makes sense: e-cigarette aerosol particles are larger than cigarette smoke particles and settle out of the air more quickly. Ventilation systems also appear to reduce secondhand e-cigarette exposure more effectively than they reduce cigarette smoke.
What Vaping Does to Your Mouth
Smoking’s connection to gum disease and tooth loss is well established. E-cigarettes appear to create a different but still troubling oral environment. A six-month study of the bacteria living beneath the gumline found that vapers harbored a microbial community distinct from both smokers and nonsmokers. The vaping microbiome shared traits with both groups but was uniquely enriched in certain bacteria, including Fusobacterium, that are linked to periodontal disease progression.22PubMed Central. Electronic Cigarette Use Promotes a Unique Periodontal Microbiome Even more striking, a separate study of people with no clinical signs of gum disease found that vapers’ oral microbiomes showed pathogen levels, virulence signatures, and inflammatory signals on par with patients who had severe periodontitis.23PubMed Central. Adverse effects of electronic cigarettes on the disease-naive oral microbiome In other words, the bacterial groundwork for serious gum disease may already be underway in vapers who look clinically healthy.
E-Cigarettes as a Quit-Smoking Tool
This is the main argument in favor of e-cigarettes at the population level: if they help current smokers switch away from combustible cigarettes, the net health benefit could be large. A well-known UK randomized trial found that e-cigarettes were roughly twice as effective as nicotine-replacement therapy for quitting smoking, with a one-year abstinence rate of 18 percent versus about 10 percent for patches, gum, and similar products, when both were accompanied by behavioral support.24PubMed. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy Other trials have been less dramatic. An earlier New Zealand trial found that nicotine e-cigarettes produced slightly higher quit rates than patches, but the differences were not statistically significant because overall quit rates were lower than expected.25The Lancet. Electronic cigarettes for smoking cessation: a randomised controlled trial A pragmatic trial found that combining nicotine patches with a nicotine e-cigarette produced a modest improvement in cessation over patches alone.26PubMed. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial
The evidence, on balance, suggests e-cigarettes can help some smokers quit, but they are not a magic solution. Many people who try to quit with e-cigarettes end up using both products (dual use), which brings its own problems. A large observational study found that dual users reported worse general health than people who only smoked cigarettes, with comparable or higher breathing difficulty scores and a higher rate of arrhythmia history.27PLoS ONE. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study If you are switching to e-cigarettes as a harm-reduction strategy, the harm reduction depends on actually stopping combustible cigarettes, not just adding a vape.
Adolescent Brains and Nicotine
For adults who already smoke, swapping to e-cigarettes may reduce certain exposures. For teenagers who have never smoked, the calculation is entirely different. The adolescent brain is still developing, and nicotine exposure during this window can cause lasting changes. Animal research has demonstrated that adolescent nicotine exposure, but not exposure after adolescence, leads to diminished attention, increased impulsivity, enhanced anxiety, and depression-like symptoms in adulthood. These effects are linked to changes in the prefrontal cortex, the brain region responsible for decision-making and impulse control.28PubMed Central. Nicotine and the adolescent brain The evidence for long-term negative impacts on the adolescent brain from nicotine is strong enough that researchers have called for longitudinal studies specifically tracking teen and young adult e-cigarette users over time.29PubMed Central. Unique, long-term effects of nicotine on adolescent brain
Because e-cigarettes make nicotine delivery smoother and more socially acceptable in settings where smoking would draw objections, they have become a primary route of nicotine initiation for young people. The harm here is not about whether vaping is “safer than smoking.” For someone who was never going to smoke, any vaping-related harm is a net addition, not a substitution.
Pregnancy and Fetal Health
Pregnant smokers sometimes switch to e-cigarettes hoping to reduce harm to the fetus. The evidence so far is not reassuring enough to endorse that switch. A systematic review of studies comparing exclusive vaping to exclusive smoking during pregnancy found that most outcomes were comparable between the two groups, with some studies finding slightly lower risk for vapers and others finding no difference.30PubMed Central. Vaping during pregnancy: a systematic review of health outcomes One large observational analysis found that while adverse outcomes appeared somewhat less common among e-cigarette-only users compared to smokers, the differences in preterm birth, low birth weight, and small-for-gestational-age babies were not statistically significant. When e-cigarette users were compared to former smokers who had quit entirely, vapers actually had a higher prevalence of low birth weight.31Scientific Reports. Patterns of combustible and electronic cigarette use during pregnancy and associated pregnancy outcomes The safest option during pregnancy remains quitting nicotine products altogether.
Systemic Inflammation
Chronic low-grade inflammation is the thread connecting many smoking-related diseases. Whether e-cigarettes drive similar systemic inflammation is genuinely unsettled. One study using national health data found that e-cigarette use was significantly associated with elevated high-sensitivity C-reactive protein, a widely used inflammation marker, as well as elevated uric acid levels.32PubMed. Association Between Electronic Cigarette Use and Levels of High-Sensitivity C-Reactive Protein and Uric Acid But a study focusing on young adult e-cigarette users found no significant differences in CRP, interleukin-6, fibrinogen, or several other inflammatory and endothelial markers compared to nonusers, after adjusting for confounders.33Tobacco Induced Diseases. Examining the association of habitual e-cigarette use with inflammation and endothelial dysfunction in young adults: The VAPORS-Endothelial function study These conflicting results likely reflect differences in populations studied, duration of use, and device type. The inflammation question is far from resolved, and any blanket statement that vaping does or does not cause systemic inflammation is ahead of the evidence.
The Population-Level Gamble
Public health officials face a genuine dilemma. If e-cigarettes help a substantial number of adult smokers quit, the years of life gained could be enormous. But if e-cigarettes also funnel teenagers into nicotine addiction and eventual cigarette use, those gains could be partially offset. Modeling exercises have attempted to weigh these competing outcomes at the population scale, estimating both the number of adults who successfully quit smoking through e-cigarette use and the number of young people who initiate nicotine through vaping and eventually transition to cigarettes.34PLoS ONE. Quantifying population-level health benefits and harms of e-cigarette use in the United States Other simulation studies have modeled various market scenarios, from highly regulated environments where e-cigarettes are available mainly for cessation to loosely regulated ones where youth uptake is high, and found that the net health effect swings dramatically depending on which scenario plays out.35JAMA Internal Medicine. Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis
The answer to “is vaping better than smoking for the population” depends on who starts vaping and whether they would have smoked otherwise. For a 45-year-old pack-a-day smoker who fully switches, the risk reduction is probably real. For a 15-year-old who picks up a disposable vape at a party, the risk is entirely new. Policy that treats these two situations identically will get one of them wrong.